Literature DB >> 231489

Current impact of adjuvant chemotherapy in resectable cancer.

A Rossi, G Bonadonna.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 231489     DOI： 10.1007/bf00254414

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  41 in total

Review 1.  Wilms' tumor--model of a curable pediatric malignant solid tumor.

Authors:  D M Green; N Jaffe
Journal:  Cancer Treat Rev       Date:  1978-09       Impact factor: 12.111

2.  Chemotherapy as an adjuvant to surgery in lung cancer.

Authors:  K Karrer; N Pridun; H Denck
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 3.  Combined modality therapy for intracranial tumors.

Authors:  H J Bloom
Journal:  Cancer       Date:  1975-01       Impact factor: 6.860

4.  Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study.

Authors:  N E Breslow; N F Palmer; L R Hill; J Buring; G J D'Angio
Journal:  Cancer       Date:  1978-04       Impact factor: 6.860

5.  Effect of CCNU on survival rate of objective remission and duration of free interval in patients with malignant brain glioma--final evaluation. E.O.R.T.C. Brain Tumor Group.

Authors: 
Journal:  Eur J Cancer       Date:  1978-08       Impact factor: 9.162

6.  The intergroup rhabdomyosarcoma study: a preliminary report.

Authors:  H M Maurer; T Moon; M Donaldson; C Fernandez; E A Gehan; D Hammond; D M Hays; W Lawrence; W Newton; A Ragab; B Raney; E H Soule; W W Sutow; M Tefft
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

7.  High-dose methotrexate in osteogenic sarcoma: a 5-year experience.

Authors:  N Jaffe; E Frei; H Watts; D Traggis
Journal:  Cancer Treat Rep       Date:  1978-02

8.  Prospective randomized evaluation of the role of limb-sparing surgery, radiation therapy, and adjuvant chemoimmunotherapy in the treatment of adult soft-tissue sarcomas.

Authors:  S A Rosenberg; H Kent; J Costa; B L Webber; R Young; B Chabner; A R Baker; M F Brennan; P B Chretien; M H Cohen; E V deMoss; H F Sears; C Seipp; R Simon
Journal:  Surgery       Date:  1978-07       Impact factor: 3.982

9.  Adjuvant cancer chemotherapy after resection of carcinoma of the lung.

Authors:  T W Shields; E W Humphrey; C E Eastridge; R J Keehn
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

10.  Advances in the staging and treatment of ovarian cancer.

Authors:  R I Fisher; R C Young
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.